Dr. Connie Yang, BC Children’s Hospital, Vancouver, BC

This presentation will review the latest CTS Guideline on the Management of Mild Asthma in Children and Adults. It will discuss whether ICS-formoterol should be used instead of short acting beta agonists and whether ICS-formoterol as needed should be used instead of daily inhaled corticosteroids.

Learning Objectives
At the end of this presentation, attendees will be able to:

  • Understand the evidence for ICS-formoterol PRN versus SABA in mild intermittent asthma; and
  • Understand the evidence for ICS-formoterol PRN versus daily inhaled corticosteroids in mild persistent asthma.